Clinical trial
Thalidomide and Cyclophosphamide in Treating Children With Recurrent or…
NCT00003754 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003754 |
|---|---|
| Title | Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers |
| Official title | A Phase II Study of Thalidomide and Cyclophosphamide in Patients With Recurrent or Refractory Malignancies |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | cyclophosphamide, thalidomide |
| Start date | Sep 1, 1998 |
| Primary completion | Jul 1, 2001 |
| Completion | Jul 1, 2001 |
| First posted | Apr 9, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: